Literature DB >> 20124938

Intraductal papillary-mucinous neoplasms of the gastric and intestinal types may have less malignant potential than the pancreatobiliary type.

Naoki Takasu1, Wataru Kimura, Toshiyuki Moriya, Ichiro Hirai, Akiko Takeshita, Yukinori Kamio, Takashi Nomura.   

Abstract

OBJECTIVES: Intraductal papillary-mucinous neoplasms (IPMNs) of the pancreas are classified into 4 types--gastric, intestinal, pancreatobiliary, and oncocytic--on the basis of their morphology and immunohistochemistry. We classified IPMNs at our institute and used this classification to determine the clinicopathological features, prognosis, and malignant potential of the 4 types.
METHODS: Sixty-one patients with IPMN who underwent surgery between 2000 and 2007 were evaluated retrospectively.
RESULTS: There were 24 tumors of the gastric type, 22 intestinal, 12 pancreatobiliary, and 3 oncocytic. Patients with the intestinal or gastric type had a better prognosis than those with the pancreatobiliary type. The intestinal and pancreatobiliary types had almost the same frequencies of carcinoma, but the intestinal type tended to have a lower frequency of invasive carcinoma than the pancreatobiliary type. Patients with invasive carcinomas derived from intestinal-type IPMNs tended to have a better prognosis than those whose invasive carcinomas were derived from the pancreatobiliary type.
CONCLUSIONS: Intraductal papillary-mucinous neoplasm of the gastric and intestinal types may have less malignant potential than that of the pancreatobiliary type. Invasive carcinomas derived from intestinal-type IPMNs may be less invasive and slower growing than those derived from the pancreatobiliary type.

Entities:  

Mesh:

Year:  2010        PMID: 20124938     DOI: 10.1097/MPA.0b013e3181c6947a

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  10 in total

Review 1.  Pathological features and diagnosis of intraductal papillary mucinous neoplasm of the pancreas.

Authors:  Víctor M Castellano-Megías; Carolina Ibarrola-de Andrés; Guadalupe López-Alonso; Francisco Colina-Ruizdelgado
Journal:  World J Gastrointest Oncol       Date:  2014-09-15

2.  Usefulness of KL-6 in the subtyping of intraductal papillary mucinous neoplasia of the pancreas, including carcinoma, dysplasia, and hyperplasia.

Authors:  Yuji Ohtsuki; Ryohei Watanabe; Masashi Kimura; Katsuyoshi Nomura; Tomoharu Maeda; Katsumi Kito; Miyuki Takeji; Gang-Hong Lee; Mutsuo Furihata
Journal:  Med Mol Morphol       Date:  2014-06-08       Impact factor: 2.309

3.  Prognostic relevance of pathologic subtypes and minimal invasion in intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Jeong Kim; Kee-Taek Jang; Sang Mo Park; Seong Woo Lim; Jung Ha Kim; Kwang Hyuck Lee; Jong Kyun Lee; Jin Seok Heo; Seong-Ho Choi; Dong Wook Choi; Jong Chul Rhee; Kyu Taek Lee
Journal:  Tumour Biol       Date:  2010-12-30

Review 4.  Hereditary and Sporadic Pancreatic Ductal Adenocarcinoma: Current Update on Genetics and Imaging.

Authors:  Ajaykumar C Morani; Abdelrahman K Hanafy; Nisha S Ramani; Venkata S Katabathina; Sireesha Yedururi; Anil K Dasyam; Srinivasa R Prasad
Journal:  Radiol Imaging Cancer       Date:  2020-03-13

5.  Interobserver variability in intraductal papillary mucinous neoplasm subtypes and application of their mucin immunoprofiles.

Authors:  Heewon A Kwak; Xiuli Liu; Daniela S Allende; Rish K Pai; John Hart; Shu-Yuan Xiao
Journal:  Mod Pathol       Date:  2016-05-20       Impact factor: 7.842

6.  Potential usefulness of mucin immunohistochemical staining of preoperative pancreatic biopsy or juice cytology specimens in the determination of treatment strategies for intraductal papillary mucinous neoplasm.

Authors:  Toru Hisaka; Hiroyuki Horiuchi; Shinji Uchida; Hiroto Ishikawa; Ryuichi Kawahara; Yusuke Kawashima; Masanori Akashi; Kazuhiro Mikagi; Yusuke Ishida; Yoshinobu Okabe; Masamichi Nakayama; Yoshiki Naito; Hirohisa Yano; Tomoki Taira; Akihiko Kawahara; Masayoshi Kage; Hisafumi Kinoshita; Kazuo Shirozu
Journal:  Oncol Rep       Date:  2013-09-05       Impact factor: 3.906

7.  Spread of Intraductal Papillary Neoplasm Arising from the Cystic Duct of the Biliary Tree.

Authors:  Yoshihiko Kadowaki; Yuki Yokota; Satoshi Komoto; Nobuhito Kubota; Takahiro Okamoto; Nobuhiro Ishido; Tsuyoshi Okino
Journal:  Case Rep Gastroenterol       Date:  2016-05-19

8.  Pancreatic resection for intraductal papillary mucinous neoplasm- a thirteen-year single center experience.

Authors:  Katharina Marsoner; Johannes Haybaeck; Dora Csengeri; James Elvis Waha; Jakob Schagerl; Rainer Langeder; Hans Joerg Mischinger; Peter Kornprat
Journal:  BMC Cancer       Date:  2016-11-04       Impact factor: 4.430

9.  Prognostic value of histological subtype in intraductal papillary mucinous neoplasm of the pancreas: A retrospective analysis of outcome from one single center.

Authors:  Yefei Rong; Dansong Wang; Chen Xu; Yuan Ji; Dayong Jin; Wenchuan Wu; Xuefeng Xu; Tiantao Kuang; Wenhui Lou
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

10.  Intraductal papillary mucinous neoplasms of the pancreas: Clinical association with KRAS.

Authors:  Xiao Yan Chang; Yan Wu; Yuan Li; Jing Wang; Jie Chen
Journal:  Mol Med Rep       Date:  2018-04-12       Impact factor: 2.952

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.